MONTREAL, June 04, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. ("PyroGenesis" or the "Company") (TSX:PYR) (OTCQX:PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that it has completed its previously announced non-brokered private placement (the "Concurrent Private Placement") that was concurrent to a "bought deal" offering (the "Offering"). The "bought deal" closed previously on June 3, 2026.
The Concurrent Private Placement was solely and entirely subscribed by Mr. P. Peter Pascali, the Company's President and CEO, for 5,882,352 units at a price per Unit of $0.34 (the "Offering Price"), for gross proceeds to the Company of $2,000,000. Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant of the Company (a "Warrant"). Each Warrant under the Concurrent Private Placement entitles Mr. Pascali to purchase one Common Share of the Company at a price of $0.42. Warrants to be issued to Mr. Pascali under the Concurrent Private Placement expire 24 months from the Closing Date of the Offering. All Units acquired pursuant to the Concurrent Private Placement will be subject to a hold period of four (4) months pursuant to applicable Canadian securities laws.
Combined, the Concurrent Private Placement and the bought deal Offering total approximately $6.2 million.
The previously closed "bought deal" Offering issued 12,514,875 units of the Company (the "Units") for aggregate gross proceeds of $4,255,057.50 at a price per Unit of $0.34 (the "Offering Price"), including the full exercise of the underwriter's option. The Offering was led by Research Capital Corporation as the sole underwriter and sole bookrunner (the "Underwriter").
Each Unit consists of one common share of the Company (a "Common ...
